This Week at AVAC: New tools and a changing landscape
View this email in your browser ([link removed])
[link removed] November 25, 2024
** Advancing choice and equity: New tools and a changing landscape
------------------------------------------------------------
Dear Advocate,
As a new US presidential administration takes shape, our commitment to championing choice, science, and rights remains unwavering. This critical moment demands intentional strategies to protect progress in HIV prevention and global health equity while staying true to our mission and values.
Given the concerning rise of health misinformation on X (formerly Twitter), we must find new ways to share accurate, science-based information. Starting this week, we’ll begin to transition our presence to BlueSky, an open-source alternative to X, alongside Instagram ([link removed]) and Facebook ([link removed]) . Learn more about Blue Sky here ([link removed]) and be sure to follow us ([link removed]) .
Read on for the latest insights on CAB for PrEP and new resources on PrEP delivery, STI R&D, and the political challenges and the priorities in 2025 and beyond.
Trials to Impact: The Latest Insights on CAB for PrEP
Insights
** Trials to Impact: The Latest Insights on CAB for PrEP
------------------------------------------------------------
The Biomedical Prevention Implementation Collaborative (BioPIC) ([link removed]) is leading an integrated and adaptable strategy to deliver new HIV prevention products, with a particular focus on longer-acting PrEP methods. The BioPIC's Adaptable Product Introduction Framework ([link removed]) , emphasizes the need to conduct early-stage activities alongside Phase III clinical trials, and conducts Think Tanks to pinpoint evidence gaps and share insights from modeling and implementation studies. This work is driving more effective, people-centered product delivery. Read more on recent CAB for PrEP insights ([link removed]) and visit the Evidence Gap Tracker ([link removed]) .
read the insights [link removed]
Resources on PrEP Delivery, STI R&D, and More!
Recording
Video Recording and English Audio ([link removed]) / Ukrainian Audio ([link removed]) / Portuguese Audio ([link removed]) / Spanish Audio ([link removed]) / Slides ([link removed]) / Resources ([link removed])
[link removed]
Recording
Recording ([link removed]) / Alison Footman Slides ([link removed]) / Mandisa Mdingi Slides ([link removed]) / Cécile Ventola Slides ([link removed]) / Birgitta Gleeson Slides ([link removed])
[link removed]
In Case You Missed It
[link removed]
KFF’s Jen Kates ([link removed]) and AVAC’s Suraj Madoori ([link removed]) lay out the challenges and the priorities in 2025 and beyond.
In the days, months and years ahead under a new US Presidential Administration, advocacy for choice, freedom, science, and rights will require intentional strategies to protect hard fought gains in HIV treatment and prevention and in global health generally, and to safeguard policies and programs that advance it. And there will be major implications for the global AIDS response.
listen to the podcast > ([link removed])
[link removed]
Advocates' Guide
** An Advocate’s Guide to Research in Pregnant and Lactating Populations
------------------------------------------------------------
Check out our updated graphic in this advocates' guide, which shares background on the need for research in pregnant and lactating populations and how advocates can advance inclusion.
read more ([link removed])
Best,
AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed]) [link removed]
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423
[email protected] (mailto:
[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])
